FDA Inspection
St. Agnes Medical Center IRBSt. Agnes Medical Center IRB – FDA Inspection, Sep 1, 2022
Record Details
This FDA Inspection record concerns St. Agnes Medical Center IRB, with an inspection on September 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- St. Agnes Medical Center IRB
- Inspection Date
- September 1, 2022
- Product Type
- Drugs
View Company Profile
ID · a1dc527e-96fe-4d26-bee3-823f25940242
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1178701
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
6- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.115(b)Retention of records
- 21 CFR 56.106(e)Changes re: review new products or discontinue reviewing
- 21 CFR 56.106(c)Renewal every 3 years
- 21 CFR 812.66No IRB notification of significant risk determination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of St. Agnes Medical Center IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2015 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| April 14, 2011 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for St. Agnes Medical Center IRB
- FDA Inspection 952398 - 2015-12-17
- FDA Inspection 720369 - 2011-04-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.